The NHS is preparing to reduce its reliance on US technology giant Palantir, potentially opening the door for British technology companies to play a bigger role in the health service.
The Government has announced that Palantir's NHS contract will end in March 2029, with the transition process expected to begin in January.
Health minister James Frith said the move would help the NHS reduce its dependence on a single technology supplier and explore opportunities for UK businesses to provide alternative systems.
Palantir, which supplies data management technology to the NHS, has faced growing scrutiny over privacy concerns, the performance of its systems and the health service's reliance on a single supplier.
Critics have questioned whether the technology is delivering the promised benefits, while campaigners have raised concerns about the handling of sensitive patient information.
The planned transition could create opportunities for British technology firms specialising in healthcare software, data management and digital infrastructure.
However, any replacement systems will need to demonstrate that they can securely manage NHS information while delivering genuine improvements for patients and healthcare professionals.
Why this is good for Britain
Giving British technology companies the opportunity to compete for major NHS contracts could support home-grown innovation, create skilled jobs and strengthen the UK's health technology sector.
It could also help the NHS build a more diverse and resilient network of technology suppliers, reducing its dependence on any single company.




